D. Capon

发表

Characterization of the human factor VIII gene

E. Chen, D. Eaton, W. Wood, 1984, Nature.

B. Keyt, H. Oppermann, W. Wood, 1984, Nature.

Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein

D. Capon, M. Muesing, Douglas H. Smith, 1987, Cell.

Multi epitope-targeting immunoprecipitation using F(ab') fragments with high affinity and specificity for the enhanced detection of a peptide with matrix-assisted laser desorption ionization-time-of-flight mass spectrometry.

Koichi Tanaka, Taka-Aki Sato, T. Shimada, 2013, Analytical chemistry.

Antiviral effects of CD4 derivatives.

D. Capon, R. H. Ward, Rebecca H. R. Ward, 1990, Current opinion in immunology.

The Structure and Bacterial Expression of Three Distinct Bovine Interferon-β Genes

D. Goeddel, D. Capon, D. Leung, 1984, Bio/Technology.

In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity

P. Earl, B. Moss, M. Martin, 1988, Journal of virology.

HIV-infected cells are killed by rCD4-ricin A chain.

V. Ghetie, D. Capon, E. Vitetta, 1988, Science.

The dnaG Gene Product of Escherichia Coli: Characterization of the Catalytic Activity

M. Gefter, D. Capon, 1978 .

A discrete element 3' of human immunodeficiency virus 1 (HIV-1) and HIV-2 mRNA initiation sites mediates transcriptional activation by an HIV trans activator

D. Capon, A. Jakobovits, D. H. Smith, 1988 .

Gene targeting in normal somatic cells: inactivation of the interferon–γ receptor in myoblasts

M. Arbonés, D. Capon, H. A. Austin, 1994, Nature Genetics.

Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin.

D. Goeddel, S. Marsters, A. Ashkenazi, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Coordinately Expressed and Encode Functional Polypeptides

D. Goeddel, D. Capon, H. Shepard, 2022 .

Targeting of human immunodeficiency virus-infected cells by CD8+ T lymphocytes armed with universal T-cell receptors

T. Dull, J. Groopman, M. Roberts, 1994 .

Targeting of human immunodeficiency virus-infected cells by CD8+ T lymphocytes armed with universal T-cell receptors.

T. Dull, J. Groopman, M. Roberts, 1994, Blood.

Comparative biochemical properties of normal and activated human ras p21 protein

D. Goeddel, A. Levinson, D. Capon, 1984, Nature.

Acetylcholine analogue stimulates DNA synthesis in brain-derived cells via specific muscarinic receptor subtypes

A. Ashkenazi, J. Ramachandran, D. Capon, 1989, Nature.

Structure of human factor VIII. Nature

B. Keyt, H. Oppermann, W. Wood, 1984 .

Functional diversity of muscarinic receptor subtypes in cellular signal transduction and growth.

A. Ashkenazi, J. Ramachandran, E. Peralta, 1989, Trends in pharmacological sciences.

Mouse Antibodies with Activity Against the SARS-CoV-2 D614G and B.1.351 Variants

B. Zabel, G. Simmons, D. Capon, 2021, bioRxiv.

Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum.

S. Shak, S. Marsters, D. Capon, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Biological properties of a CD4 immunoadhesin

F. Wurm, S. Marsters, J. Groopman, 1990, Nature.

Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen.

S. Marsters, J. Groopman, D. Capon, 1987, Science.

Class II MHC molecules and the HIV gp 120 envelope protein interact with functionally distinct regions of the CD4 molecule.

Eric O Long, D. Karp, D. Lamarre, 1989, The EMBO journal.

Functionally distinct G proteins selectively couple different receptors to PI hydrolysis in the same cell

A. Ashkenazi, J. Ramachandran, E. Peralta, 1989, Cell.

Structural and functional diversity of muscarinic acetylcholine receptor subtypes.

A. Ashkenazi, J. Ramachandran, E. Peralta, 1989, Progress in clinical and biological research.

The MHC-binding and gp120-binding functions of CD4 are separable.

D. Lamarre, R. Sékaly, A. Ashkenazi, 1989, Science.

Flexible antibodies with nonprotein hinges

P. Hwang, F. Wurm, Koichi Tanaka, 2011, Proceedings of the Japan Academy. Series B, Physical and biological sciences.

Designing CD4 immunoadhesins for AIDS therapy

H. Mitsuya, S. Broder, F. Wurm, 1989, Nature.

Prevention of HIV-1 IIIB infection in chimpanzees by CD4 immunoadhesin

J. Mordenti, D. Capon, James D. Green, 1991, Nature.

Structure and organization of the human Ki-ras proto-oncogene and a related processed pseudogene

E. Chen, P. Seeburg, D. Goeddel, 1983, Nature.

Bispecific antibodies that mediate killing of cells infected with human immunodeficiency virus of any strain.

K. Steimer, M. Wabl, H. Jäck, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Bacterial expression of the acquired immunodeficiency syndrome retrovirus p24 gag protein and its use as a diagnostic reagent.

D. Dowbenko, L. Lasky, J. Groopman, 1985, Proceedings of the National Academy of Sciences of the United States of America.

Expression of active human factor VIII from recombinant DNA clones

B. Keyt, P. Seeburg, E. Delwart, 1984, Nature.

A Novel Phenotypic Drug Susceptibility Assay for Human Immunodeficiency Virus Type 1

Christos J. Petropoulos, Terri Wrin, Jeannette M. Whitcomb, 2000, Antimicrobial Agents and Chemotherapy.

Differential regulation of PI hydrolysis and adenylyl cyclase by muscarinic receptor subtypes

A. Ashkenazi, J. Ramachandran, E. Peralta, 1988, Nature.

Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor

G. Nakamura, L. Lasky, P. Berman, 1987, Cell.

Biological properties of human c-Ha-ras1 genes mutated at codon 12

P. Seeburg, D. Goeddel, A. Levinson, 1984, Nature.

Mapping the CD4 binding site for human immunodeficiency virus by alanine-scanning mutagenesis.

L. Presta, S. Marsters, A. Ashkenazi, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Distinct primary structures, ligand‐binding properties and tissue‐specific expression of four human muscarinic acetylcholine receptors.

A. Ashkenazi, J. Ramachandran, E. Peralta, 1987, The EMBO journal.

Functional role of muscarinic acetylcholine receptor subtype diversity.

A. Ashkenazi, J. Ramachandran, E. Peralta, 1988, Cold Spring Harbor symposia on quantitative biology.

Serodiagnosis of Antibodies to the Human AIDS Retrovirus with a Bacterially Synthesized env Polypeptide

J. Lanigan, L. Lasky, J. Groopman, 1986, Bio/Technology.

Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein.

G. Nakamura, D. Dowbenko, L. Lasky, 1986, Science.

Primary structure and biochemical properties of an M2 muscarinic receptor.

A. Ashkenazi, J. Ramachandran, E. Peralta, 1987, Science.

Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue

E. Chen, P. Seeburg, D. Goeddel, 1983, Nature.

An M2 muscarinic receptor subtype coupled to both adenylyl cyclase and phosphoinositide turnover.

A. Ashkenazi, J. Ramachandran, E. Peralta, 1987, Science.

Structure of the human and murine R-ras genes, novel genes closely related to ras proto-oncogenes

D. Goeddel, S. Naylor, E. Delwart, 1987, Cell.

Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus

L. Lasky, D. Capon, C. Benton, 1985, Nature.

The structural and functional interrelationships of muscarinic acetylcholine receptor subtypes

A. Ashkenazi, J. Ramachandran, E. Peralta, 1989, BioEssays : news and reviews in molecular, cellular and developmental biology.

Two distinct families of human and bovine interferon-alpha genes are coordinately expressed and encode functional polypeptides

D. Goeddel, H. Shepard, D. Capon, 1985, Molecular and cellular biology.

A discrete element 3' of human immunodeficiency virus 1 (HIV-1) and HIV-2 mRNA initiation sites mediates transcriptional activation by an HIV trans activator

D. Capon, A. Jakobovits, D. H. Smith, 1988, Molecular and cellular biology.

Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice.

K. Ley, T. Tedder, M. Arbonés, 1994, Immunity.

Characterization of in vitro inhibition of human immunodeficiency virus by purified recombinant CD4

J. Groopman, D. Capon, S. Chamow, 1989, Journal of virology.

dnaG (primase)-dependent origins of DNA replication. Nucleotide sequences of the negative strand initiation sites of bacteriophages St-1, phi K, and alpha 3.

D. Capon, D. Dressler, J. Sims, 1979, The Journal of biological chemistry.

The CD4-gp120 interaction and AIDS pathogenesis.

D. Capon, R. H. Ward, R. Ward, 1991, Annual review of immunology.

Antigen–specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs

H. Abderrahim, D. Capon, R. McGuinness, 1994, Nature Genetics.

Mechanism of DNA chain initiation by the dnaG protein of Escherichia coli

D. Capon, 1981 .

Structural basis of muscarinic acetylcholine receptor subtype diversity.

A. Ashkenazi, J. Ramachandran, E. Peralta, 1988, Trends in pharmacological sciences.

Trans‐activation of HIV‐1 LTR‐directed gene expression by tat requires protein kinase C.

D. Capon, A. Rosenthal, A. Jakobovits, 1990, The EMBO journal.

Topologically engineered antibodies and Fc-fusion proteins: a new class of multifunctional therapeutic candidates for SARS-CoV-2, cancer, and other disease

M. Gefter, G. Simmons, D. Capon, 2022, bioRxiv.

Enzymatic cleavage of a CD4 immunoadhesin generates crystallizable, biologically active Fd-like fragments.

P. Bjorkman, A. Ashkenazi, M. Mulkerrin, 1990, Biochemistry.

Resistance of primary isolates of human immunodeficiency virus type 1 to soluble CD4 is independent of CD4-rgp120 binding affinity.

D. Ho, S. Marsters, A. Ashkenazi, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Activation of Ki-ras2 gene in human colon and lung carcinomas by two different point mutations

P. Seeburg, D. Goeddel, A. Levinson, 1983, Nature.

Gene targeting in normal somatic cells: inactivation of the interferon-gamma receptor in myoblasts.

M. Arbonés, D. Capon, H. A. Austin, 1994, Nature Genetics.

CD4 immunoadhesins in anti-HIV therapy: new developments.

A. Ashkenazi, J. Allen, D. Capon, 1992, International journal of cancer. Supplement = Journal international du cancer. Supplement.